Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing betamethasone in ocular dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone-containing product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and neomycin in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone- and clotrimazole-containing product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone- and neomycin-containing product in ocular dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and clotrimazole (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and fusidic acid (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone only product |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and calcipotriol only product |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and clioquinol (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and neomycin only product |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and salicylic acid only product |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and clioquinol only product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and clotrimazole only product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and fusidic acid only product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and salicylic acid only product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone only product in ocular dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and neomycin in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone in oral dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone in parenteral dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone acetate |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone sodium phosphate |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 nanogram/mg cutaneous ointment |
Has basis of strength substance (attribute) |
False |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone 120 microgram/mL oral solution |
Has precise active ingredient |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone 120 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone 500 microgram orodispersible tablet |
Has precise active ingredient |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone 500 microgram orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone only product in nasal dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone in oromucosal dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and calcipotriol only product in cutaneous dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing only betamethasone in oromucosal dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone-containing product in nasal dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone only product in otic dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone- and neomycin-containing product in otic dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and neomycin in nasal dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and neomycin only product in nasal dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and calcipotriol in cutaneous dose form (medicinal product form) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone-containing product in otic dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone and neomycin only product in otic dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone ester |
Is modification of (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous foam |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Augmented betamethasone dipropionate |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
propionate de clobétasol (substance) |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone ester |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone benzoate |
est un(e) (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Allergy to betamethasone (finding) |
Causative agent |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing betamethasone (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Intramuscular injection of betamethasone |
substance utilisée (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone 500micrograms soluble tablet (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 500 microgram oral tablet |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 4mg/mL injection solution 1mL ampule (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 0.1% scalp application (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 0.1% cream (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 0.1% ointment (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 0.1% lotion (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone+salicylic acid 0.05/3% scalp application (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 nanogram/mg cutaneous ointment |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone + antimicrobials (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone+clotrimazole 0.05/1% cream (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing betamethasone and clioquinol (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and clotrimazole (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone and fusidic acid (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone+neomycin sulfate (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing betamethasone and salicylic acid (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing betamethasone in topical dosage form (medicinal product form) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone-containing product in oral dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Betamethasone-containing product in parenteral dose form |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone 0.6mg/5mL syrup (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Betamethasone dipropionate + clotrimazole 0.5mg/10mg lotion (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product) |
a pour principe actif (attribut) |
False |
Betamethasone |
Inferred relationship |
Some |
|
Product containing betamethasone and calcipotriol (medicinal product) |
a pour principe actif (attribut) |
True |
Betamethasone |
Inferred relationship |
Some |
1 |